• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

A New nanoparticle glycogen for development of vaccine against malaria

Research Project

  • PDF
Project/Area Number 26460511
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Parasitology (including sanitary zoology)
Research InstitutionKagoshima University

Principal Investigator

Miyata Takeshi  鹿児島大学, 農水産獣医学域農学系, 准教授 (20448591)

Project Period (FY) 2014-04-01 – 2017-03-31
Keywordsマラリア / ワクチン / 伝搬阻止 / 三日熱マラリア原虫
Outline of Final Research Achievements

We have developed a new technology to enhance immune responses by generating complex which composed DNA-binding protein fused vaccine antigen, DNA and nano-particle glycogen (NPG). In this system, NPG was used as scaffold material, DNA was used as crosslinker material for vaccine antigen and NPG. New tricomponent vaccine complex (DBP-Vaccine/DNA/NPG) function was evaluated using an ookinete surface protein of Plasmodium vivax, Pvs25. The tricomplex immunized mice were conferred a high immune response compared to Pvs25 alone or DBP-Pvs25/DNA complex immunized groups. This system may be a promising approach for development of subunit vaccines against malaria.

Free Research Field

医歯薬学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi